🔎 Trials Near Me

Hjem › Bronkialkreft › Illinois

Kliniske studier for Bronkialkreft i Illinois

5 studier for Bronkialkreft søker deltakere på steder i Illinois.

Byer i Illinois

Offisiell studietekst (engelsk)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • University of Illinois at Chicago, Chicago
  • University of Chicago Hospital, Chicago
  • Springfield Clinic Main Campus, Springfield
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  • Illinois Cancer Specialists, Arlington Heights
  • University of Illinois Hospital and Health Sciences Systems, Chicago
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07185997

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • Advocate Aurora Health, Park Ridge
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT04614103

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • University of Chicago, Chicago
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Edward Hines Jr. VA Hospital, Hines, IL, Hines
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 19. feb. 2026 · NCT02984761

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.